Design Therapeutics, Inc.

Q2 2023 13F Holders

Symbol
DSGN
CUSIP
25056L103
Type
Equity
Class
COM
Num filers
98
Total reported value, excl. options
$244M
Manager Report Date Value ($000) Shares